Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy AtriCure stock
Own AtriCure stock in just a few minutes.
AtriCure, Inc is a medical instruments & supplies business based in the US. AtriCure shares (ATRC) are listed on the NASDAQ and all prices are listed in US Dollars. AtriCure employs 750 staff and has a trailing 12-month revenue of around USD$206.5 million.
How to buy shares in AtriCure
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for AtriCure. Find the stock by name or ticker symbol: ATRC. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until AtriCure reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of AtriCure, depending on your broker.
- Check in on your investment. Congratulations, you own a part of AtriCure. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
AtriCure share price
Use our graph to track the performance of ATRC stocks over time.AtriCure shares at a glance
Information last updated 2021-04-08.
| 52-week range | USD$34.04 - USD$68 |
|---|---|
| 50-day moving average | USD$64.2554 |
| 200-day moving average | USD$51.8139 |
| Wall St. target price | USD$70.14 |
| PE ratio | N/A |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$-0.565 |
Buy AtriCure shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy AtriCure stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
AtriCure financials
| Revenue TTM | USD$206.5 million |
|---|---|
| Gross profit TTM | USD$149.3 million |
| Return on assets TTM | -3.78% |
| Return on equity TTM | -14.6% |
| Profit margin | -23.32% |
| Book value | $9.094 |
| Market capitalisation | USD$3 billion |
TTM: trailing 12 months
Shorting AtriCure shares
There are currently 2.0 million AtriCure shares held short by investors – that's known as AtriCure's "short interest". This figure is 24% down from 2.6 million last month.
There are a few different ways that this level of interest in shorting AtriCure shares can be evaluated.
AtriCure's "short interest ratio" (SIR)
AtriCure's "short interest ratio" (SIR) is the quantity of AtriCure shares currently shorted divided by the average quantity of AtriCure shares traded daily (recently around 456284.22273782). AtriCure's SIR currently stands at 4.31. In other words for every 100,000 AtriCure shares traded daily on the market, roughly 4310 shares are currently held short.
However AtriCure's short interest can also be evaluated against the total number of AtriCure shares, or, against the total number of tradable AtriCure shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case AtriCure's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 AtriCure shares in existence, roughly 40 shares are currently held short) or 0.0515% of the tradable shares (for every 100,000 tradable AtriCure shares, roughly 52 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against AtriCure.
Find out more about how you can short AtriCure stock.
AtriCure share dividends
We're not expecting AtriCure to pay a dividend over the next 12 months.
AtriCure share price volatility
Over the last 12 months, AtriCure's shares have ranged in value from as little as $34.04 up to $68. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while AtriCure's is 1.0375. This would suggest that AtriCure's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
AtriCure overview
AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems to medical centers in the United States, Europe, Asia, and internationally. It offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation devices, such as the MAX Pen device that enables surgeons to evaluate cardiac arrhythmias, perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and the Coolrail device, which enable users to make longer linear lines of ablation. The company also provides cryoICE Cryoablation System that enables the user to make linear ablations of varied lengths; EPi-Sense Guided Coagulation System, a single-use disposable device used to treat symptomatic persistent and long-standing persistent atrial fibrillation patients; AtriClip System, an implantable device coupled to a single-use disposable applier; and LARIAT System, a suture-based solution for soft-tissue closure compatible with a range of anatomical shapes. In addition, it sells Lumitip Dissectors to separate tissues to provide access to key anatomical structures that are targeted for ablation; COBRA Fusion Surgical Ablation System; Fusion Magnetic Retriever System; and various reusable cardiac surgery instruments, which are used during surgical procedures for repair or replacement of certain heart valves. The company markets and sells its products through independent distributors and direct sales personnel. AtriCure, Inc. was incorporated in 2000 and is headquartered in Mason, Ohio.
Frequently asked questions
More guides on Finder
-
How to buy Sigma Labs stock
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
-
How to buy Simpson Manufacturing CoInc stock
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
-
How to buy Sequans Communications S-A stock
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
-
How to buy SFL Corporation stock
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
-
How to buy Senmiao Technology stock
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
-
How to buy Sensata Technologies Holding stock
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
-
How to buy Select Bancorp stock
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
-
How to buy Second Sight Medical Products stock
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
-
How to buy Sibanye Stillwater stock
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
-
How to buy Shinhan Financial Group CoLtd stock
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.
Ask an Expert